[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]

[[ timeLabel ]] WATCH LIVE:

Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Contact

Faster, Cleaner, Better.

quotes
- Price Overview
- Performance Report
charts
- Interactive Chart
- Snapshot Chart
technicals
options
options strategies
company
analysts
- Earnings Estimates
- Analyst Ratings
financials

Stevanato Group S.P.A. (STVN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

News & Headlines for [[ item.sessionDateDisplayLong ]]

Notes

Alerts

Watch

Help

Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management Business Wire - Mon Jun 8, 5:30AM CDT

The fixed-dose, multi-use pen injector platform features a pull-push mechanism designed to reduce use error while supporting delivery volumes up to 0.75 mL

Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting Business Wire - Wed Jun 3, 4:45PM CDT

All Resolutions Proposed to Shareholders Passed

Stevanato: Q1 Earnings Snapshot AP - Thu May 7, 5:41AM CDT

Stevanato: Q1 Earnings Snapshot

Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026 Business Wire - Thu May 7, 5:30AM CDT

- The Company Maintains Fiscal 2026 Guidance -

Stevanato Group to Participate in Three Upcoming Investor Conferences Business Wire - Mon May 4, 4:45PM CDT

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026 Business Wire - Thu Apr 23, 3:05PM CDT

Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum Business Wire - Thu Mar 12, 3:45PM CDT

Stevanato: Q4 Earnings Snapshot AP - Wed Mar 4, 5:48AM CST

Stevanato: Q4 Earnings Snapshot

Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins Business Wire - Wed Mar 4, 5:30AM CST

- Establishes Fiscal 2026 Guidance -

Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026 Business Wire - Thu Feb 19, 5:30AM CST

MAIN MENU

POPULAR

quotes

charts

technicals

options

options strategies

company

analysts

financials

Stevanato Group S.P.A. (STVN)

Barchart Exclusives

Want to use this as
your default charts setting?

Switch the Market flag

Want Streaming Chart Updates?

Need More Chart Options?

MAIN MENU

POPULAR

quotes

charts

technicals

options

options strategies

company

analysts

financials

Stevanato Group S.P.A. (STVN)

Barchart Exclusives

Want to use this as your default charts setting?

Switch the Market flag

Want Streaming Chart Updates?

Need More Chart Options?

Want to use this as
your default charts setting?